Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.

[1]  Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Intercomparison of treatment concepts for 3D image guided brachytherapy of cervical carcinoma based on a GEC-ESTRO study protocol , 2004 .

[3]  R. Pötter,et al.  Reporting time-dose pattern in intra-cavitary brachytherapy. Considerations on a common language using the linear quadratic model , 2004 .

[4]  R. Pötter,et al.  Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Richard Pötter,et al.  The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  R. Crevoisier,et al.  Curiethérapie dans les cancers du col utérin : évolution des techniques et des concepts , 2003 .

[7]  R. Crevoisier,et al.  Mise au point Curiethérapie dans les cancers du col utérin : évolution des techniques et des concepts Brachytherapy in cervix cancers: techniques and concepts evolution , 2003 .

[8]  B. Erickson The sculpted pear: An unfinished brachytherapy tale. , 2003, Brachytherapy.

[9]  R. Pötter,et al.  Reporting in Brachytherapie: dose and volume specification , 2002 .

[10]  John M Buatti,et al.  Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. , 2002, International journal of radiation oncology, biology, physics.

[11]  A. Gerbaulet,et al.  The GEC ESTRO handbook of brachytherapy , 2002 .

[12]  T. Hellebust,et al.  Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  M. Kinay,et al.  Optimization in high dose rate brachytherapy for utero-vaginal applications. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  A Wambersie,et al.  Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  R. Pötter,et al.  Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  7Dose-volume histogram analysis for tumor and critical organs in intracavitary brachytherapy of cervical cancer with the use of MRI , 2001 .

[17]  J. Nevinson,et al.  5CT based brachytherapy planning and complimentary bioeffect dosimetry: Evaluation of combined brachytherapy and external beam radiotherapy dose distributions, in the treatment of cervical cancer , 2001 .

[18]  S. Wachter,et al.  6The impact of MRI on the delineation of gross tumour volume in cervical cancer treatment planning: An interobserver analysis , 2001 .

[19]  R. Pötter,et al.  Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. , 2000, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[20]  R. Crevoisier,et al.  Radiochimiothérapie concomitante dans les cancers du col de l'utérus : modifications des standards , 2000 .

[21]  B. Fervers,et al.  Radiochimiothérapie concomitante dans les cancers du col de l’utérus : analyse critique des données et mise à jour des standards, options et recommandations , 1999 .

[22]  J N Brunt,et al.  Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability. , 1999, The British journal of radiology.

[23]  J C Ehrhardt,et al.  Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. , 1997, International journal of radiation oncology, biology, physics.

[24]  J. Masselot,et al.  MR imaging during intracavitary brachytherapy of vaginal and cervical cancer: preliminary results. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  H. Hricak,et al.  Cervical Carcinoma: Computed Tomography and Magnetic Resonance Imaging for Preoperative Staging , 1995, Obstetrics and gynecology.

[26]  D. Ash High Dose Rate Brachytherapy - A Textbook , 1995, British Journal of Cancer.

[27]  S. Nag High dose rate brachytherapy : a textbook , 1994 .

[28]  J. Han,et al.  Preoperative Staging of Uterine Cervical Carcinoma: Comparison of CT and MRI in 99 Patients , 1993, Journal of computer assisted tomography.

[29]  J. Fowler,et al.  High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. , 1992, International journal of radiation oncology, biology, physics.

[30]  F. Ebner,et al.  Magnetic resonance imaging in cervical cancer: a basis for objective classification. , 1989, Gynecologic oncology.

[31]  T. Nakanishi Cervix Cancer , 1987, Cancer Treatment and Research.

[32]  J. Remington,et al.  Pneumocystis and fungal infection in patients with malignancies. , 1976, International journal of radiation oncology, biology, physics.